Hydroxychloroquine is promising for neuroprotection in primary progressive MS: an open label, single arm, Phase II futility trial

M. Koch, S. Kaur,K. Sage,J. Kim, M. Levesque-Roy, G. Cerchiaro,V. W. Yong,G. Cutter,L. Metz

MULTIPLE SCLEROSIS JOURNAL(2021)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要